Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis

Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes

(2016) E. Lontchi-Yimagou et al.   DIABETIC MEDICINE

Association of HLA class II markers with autoantibody-negative ketosis-prone atypical diabetes compared to type 2 diabetes in a population of sub-Saharan African patients

(2015) Eric V. Balti et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The Genetic Profile from HLA and Non-HLA Loci Allows Identification of Atypical Type 2 Diabetes Patients

(2015) Matias Fabregat et al.   Journal of Diabetes Research

Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes

(2014) Marco C. Amato et al.   PLoS One

Islet-Specific T-Cell Responses and Proinflammatory Monocytes Define Subtypes of Autoantibody-Negative Ketosis-Prone Diabetes

(2013) B. M. Brooks-Worrell et al.   DIABETES CARE

Pathogenesis of A- + Ketosis-Prone Diabetes

(2012) S. G. Patel et al.   DIABETES

 - and  -Cell Dysfunctions in Africans With Ketosis-Prone Atypical Diabetes During Near-Normoglycemic Remission

(2012) S.-P. Choukem et al.   DIABETES CARE

Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances

(2012) Nasser M. Al-Daghri et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

(2011) Michel P Hermans et al.   Cardiovascular Diabetology

Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory

(2011) Carla Giordano et al.   European Journal of Internal Medicine

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk

(2010) M. C. Amato et al.   DIABETES CARE